Evidence map›Paper›PMID 11991638›Full record

ArticleRNA (New York, N.Y.)2002

Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis.

Melissa S Jurica, Lawrence J Licklider, Steven R Gygi, Nikolaus Grigorieff, Melissa J Moore

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 202 papers.

0numbers the graph read from it
0cells of the map it votes in
202citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

202 citing papers in PubMed, 370 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. DDX41: exploring the roles of a versatile helicase.Biochemical Society transactions · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. LncRNALife science alliance · 2022
    Article

142 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Melissa S JuricaHoward Hughes Medical Institute, Department of Biochemistry, Brandeis University, Waltham, Massachusetts 02454, USA.
Lawrence J Licklider
Steven R Gygi
Nikolaus Grigorieff
Melissa J Moore
Howard Hughes Medical Institute · USHarvard University · US

Funding

Single particle reconstructionP01GM062580 · NIGMS · HARVARD MEDICAL SCHOOL · PI HARRISON, STEPHEN COPLAN · 2001 to 2016
$23.7M
The second step of pre-mRNA splicingR01GM053007 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MOORE, MELISSA J. · 1995 to 2018
$5.6M
NHGRI NIH HHS HG00041NIGMS NIH HHS GM53007NIGMS NIH HHS GM62580
6 · The paper itself

Abstract

We describe characterization of spliceosomes affinity purified under native conditions. These spliceosomes consist largely of C complex containing splicing intermediates. After C complex assembly on an MS2 affinity-tagged pre-mRNA substrate containing a 3' splice site mutation, followed by RNase H digestion of earlier complexes, spliceosomes were purified by size exclusion and affinity selection. This protocol yielded 40S C complexes in sufficient quantities to visualize in negative stain by electron microscopy. Complexes purified in this way contain U2, U5, and U6 snRNAs, but very little U1 or U4 snRNA. Analysis by tandem mass spectrometry confirmed the presence of core snRNP proteins (SM and LSM), U2 and U5 snRNP-specific proteins, and the second step factors Prp16, Prp17, Slu7, and Prp22. In contrast, proteins specific to earlier splicing complexes, such as U2AF and U1 snRNP components, were not detected in C complex, but were present in similarly purified H complex. Images of these spliceosomes revealed single particles with dimensions of approximately 270 x 240 A that assort into well-defined classes. These images represent an important first step toward attaining a comprehensive three-dimensional understanding of pre-mRNA splicing.

Indexed as

Cell Cycle ProteinsDNA-Binding ProteinsRibonucleoproteins, Small NuclearSaccharomyces cerevisiae ProteinsAdenosine TriphosphatasesDEAD-box RNA HelicasesFungal ProteinsMass SpectrometryMicroscopy, ElectronRibonuclease HRNA-Binding ProteinsRNA HelicasesRNA PrecursorsRNA, Small NuclearRNA SplicingRNA Splicing FactorsAdenosine TriphosphatasesCDC40 protein, S cerevisiaeCell Cycle ProteinsDEAD-box RNA HelicasesDNA-Binding ProteinsFungal ProteinsPRP16 protein, S cerevisiaePRP2 protein, S cerevisiaeRibonuclease HRibonucleoproteins, Small NuclearRNA-Binding ProteinsRNA HelicasesRNA PrecursorsRNA, Small NuclearRNA Splicing FactorsSaccharomyces cerevisiae ProteinsSLU7 protein, S cerevisiaeU2 small nuclear RNAU6 small nuclear RNA

Identifiers

PMID11991638
PMCPMC1370266
OpenAlexW2162338462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.